Cyclosporine


Article Author:
Carolina Tapia
Brandon Basehore


Article Editor:
Patrick Zito


Editors In Chief:
Hela KCHIR
Joseph Lee
Savio John


Managing Editors:
Avais Raja
Orawan Chaigasame
Carrie Smith
Abdul Waheed
Khalid Alsayouri
Trevor Nezwek
Radia Jamil
Patrick Le
Anoosh Zafar Gondal
Saad Nazir
William Gossman
Hassam Zulfiqar
Hussain Sajjad
Steve Bhimji
Muhammad Hashmi
John Shell
Matthew Varacallo
Heba Mahdy
Ahmad Malik
Sarosh Vaqar
Mark Pellegrini
James Hughes
Beata Beatty
Beenish Sohail
Nazia Sadiq
Hajira Basit
Phillip Hynes


Updated:
9/2/2019 9:47:37 PM

Indications

Cyclosporin is an immunosuppressive agent used to treat organ rejection post-transplant. It is also used for certain other autoimmune diseases.[1][2][3][4][5]

In solid organ transplantation, it is used for the treatment of organ rejection in kidney, liver, and heart allogeneic transplants.

In patients with rheumatoid arthritis, it is indicated when the disease has not adequately responded to methotrexate.

For psoriasis, it is indicated for the treatment of adult, nonimmunocompromised patients with severe, recalcitrant, plaque psoriasis who have not responded to at least one systemic therapy.

In patients with amyotrophic lateral sclerosis (ALS or Lou Gehrig's disease), cyclosporin is used to treat amyotrophic lateral sclerosis and its variants.

In nephrotic syndrome, it is indicated to treat focal segmental glomerulosclerosis not responding to corticosteroids.

In individuals with graft vs. host disease (GVHD), it prevents and treats the disease.

In the case of uveitis, cyclosporin is indicated for refractory posterior uveitis and Behcet's disease.

Non- FDA approved indications include:

  • Allergic conjunctivitis, keratoconjunctivitis, Langerhans cells histiocytosis, ocular graft vs. host disease, autoimmune hepatitis, Duchenne muscular dystrophy, ulcerative colitis, pure red cell aplasia, Henoch Schonlein purpura nephritis

Mechanism of Action

Cyclosporine has been demonstrated to suppress cell-mediated immune reactions. Research has detected no effects on phagocytic function in animals, and it does not cause bone marrow suppression in animal or human models.[6][7]

The mechanism of action of cyclosporine is as a calcineurin inhibitor, a cytochrome P450 3A4 inhibitor, and P-glycoprotein inhibitor. Cyclosporin A (CsA) inhibits the synthesis of interleukins (IL), including IL-2, which is essential for self-activation T lymphocytes (LT) and their differentiation. Cyclosporine is effective due to specific and reversible inhibition of immunocompetent lymphocytes in the G0- and G1-phase of the cell cycle. The T-helper cell is the primary target, although it may also suppress T-suppressor cells. The LT-B-lymphocyte (LB) co-operation is essential for activation of LB; the latter also gets inhibited. Research has demonstrated that CsA had an inhibiting effect on CD4+ CD25+ Tregs, which might block the host immune tolerance potentiality

Metabolism: Via hepatic CYP3A4undergoes metabolism into a pair of hydroxylated derivatives (AM1 and AM9), and one N-methylated derivative (AM4N).

Enzymes inhibited: CYP3A4 and P-glycoprotein

Half-Life: 8.4-27 hours: The time to peak blood cyclosporine concentrations (Tmax) ranges from 1.5 to 2 hours following oral administration of Cyclosporine Oral Solution USP MODIFIED.

Clearance: 5 to 7 mL/min/kg in patients recipients of renal or liver allografts, appears to be somewhat slower in cardiac transplant patients.

Excretion: Mainly bile and feces

Factors that are known to influence absorption: time post-transplant, bile flow, dietary composition, gastrointestinal state, liver function, small bowel length, vehicle.

Administration

Dosing for Organ Transplant in Adults

Oral

  • Four to 12 hours pre-transplant: 14 to 18 mg/kg by mouth for one dose
  • One to two weeks post-transplant: 5 to 15 mg/kg per day by mouth divided twice a day
  • Reduce the dose by 5% per week until 5 to 10 mg/kg per day by mouth divided twice per day

Intravenous (IV) (maximum concentration 2.5 mg/dL)

  • Four to 12 hours pre-transplant IV: 5 to 6 mg/kg IV for one dose over 2 to 6 hours
  • Post-transplant, until the patient can tolerate oral therapy: 2 to 10 mg/kg IV once per day

Focal Segmental Glomerulosclerosis: Oral 3 mg/kg/day every 12 hours

Rheumatoid Arthritis: Oral (modified): Initially: 2.5 mg /kg per day every 12 hrs, increase 0.5 to 0.75 mg /kg per day after eight weeks if the response has not been effective. Maximum dose: 4 mg/kg per day

Psoriasis: Oral (modified): Initially: 2.5 mg/kg per day every 12 hours, increase 0.5 mg/kg per day after four weeks if the response has not been effective. Maximum dose: 4 mg/kg per day

Adjust dosage according to trough levels.

Adverse Effects

Adverse effects include[8][9][10]:

  • Cardiovascular: hypertension, arrhythmia
  • Renal System: Decreases glomerular filtration rate (GFR) due to an increased tone of the glomerular afferent arterioles. Serum creatinine concentration rises and decreases creatinine clearance. The undesirable effects correlate with duration of treatment an dose.
  • Endocrinological and metabolic: Dyslipidemia (predisposing factors such as hypertension), hypomagnesemia, hyperkalemia, gynecomastia hypertrichosis.
  • Neurotoxicity: There have been reports of convulsions, especially in combination with high dose methylprednisolone, encephalopathy, anxiety, headache, and fever.
  • Others: There is an increased risk for the development of skin and lymphoproliferative malignancies in cyclosporine-treated psoriasis patients. Increase in the occurrence of malignant lymphomas. Increase the level of inflammatory cytokines such as TNF-alfa. Increase the infection risk.

Contraindications

 Contraindications to cyclosporin include:

  • Drugs: amphotericin B deoxycholate, atorvastatin, bosentan, cidofovir, elbasvir/grazoprevir, flibanserin, lomitapide, mifepristone, neomycin oral, pitavastatin, saquinavir, simvastatin, sitaxentan, tacrolimus
  • BCG
  • Attenuated vaccine
  • Hypersensitivity to cyclosporine or any of the ingredients of the formulation (such as polyoxyethylated castor oil).
  • Active infection
  • Patients with impaired renal function
  • Asthma
  • History of blood dyscrasias
  • Uncontrolled hypertension
  • In the case of psoriasis: Concomitant PUVA therapy, ultraviolet B (UVB) radiation, coal tar, methotrexate, other immunosuppressants

Monitoring

Patient BUN/SCr, Mg++, and blood pressure require monitoring while on therapy.  Uric acid monitoring is debatable.

Therapeutic monitoring of cyclosporine in transplant patients is a valuable tool in adjusting drug dosage to prevent acute rejection, nephrotoxicity, and predictable dose-dependent adverse reactions.

The ideal therapeutic range of cyclosporine in whole blood as follows: 

Kidney transplant: 200 to 400 ng/ml in the first week of post-transplantation; 125 to 275 ng/ml in the second week to the sixth month of post-transplantation; 100 to 150 ng/ml in the seventh to twelfth month of post-transplantation; and 75 to 160 ng/ml 1 year after post-transplantation (residual concentration predose)

Heart transplant: 250 to 350 ng/mL on the first 6 months; 100 to 200 ng/mL in 6 months to 1 year after post-transplantation (residual concentration predose)

Liver transplant: 250 to 350 ng/mL for the first 6 months; 100-200 ng/mL in the sixth month to 1 year after post-transplantation (residual concentration predose)

The range between effective cyclosporine concentrations and the concentrations associated with serious toxicity is fairly narrow.

Sub-optimal doses or concentrations can lead to therapeutic failure or severe toxicity.

Cyclosporine is subject to therapeutic monitoring based on pharmacokinetics measures.

Cyclosporine has low-to-moderate within-subject variability.

Toxicity

In the event of toxicity, establishing a patent airway is a priority. Watch for signs of respiratory insufficiency and provide ventilation assistance if needed. Monitor for shock and treat if necessary. Anticipate seizures and treat if necessary, and initiate supportive and symptomatic treatment. When overdosage occurs in patients prescribed cyclosporine therapy, the drug may be withheld for a few days, or alternate-day therapy initiated until the patient stabilizes.

Hemodialysis only eliminates 1% of the dose.

Monitoring serum CsA levels is mandatory, and patients may need multiple dose adjustments during the treatment period. The CVC (central venous catheter) line not used to infuse CsA can be safely used to collect blood samples for serum CsA levels. The procedure can be performed immediately after interrupting the infusion if using the appropriate technique for discarding 5 mL of blood.

Drugs that can decrease CsA levels: Rifampicin, rifabutin, isoniazid, barbiturates, phenytoin, carbamazepine, IV trimethoprim, IV sulfadimidine, imipenem, cephalosporins, terbinafine, ciprofloxacin, ticlopidine, octreotide, and nefazodone.

Drugs that can increase CsA levels: Verapamil, diltiazem, amlodipine, nicardipine, ketoconazole, fluconazole, itraconazole, erythromycin, clarithromycin, azithromycin, saquinavir, indinavir, nelfinavir, ritonavir, methylprednisolone.

Enhancing Healthcare Team Outcomes

Cyclosporine is widely used as an immunosuppressive drug, especially in transplant patients. The majority of patients on cyclosporine are followed as outpatients by the nurse practitioner, primary care provider, an internist, and the specialist. The levels of cyclosporine must be obtained regularly to prevent acute rejection, nephrotoxicity, and predictable dose-dependent adverse reactions.

Further, the pharmacist and nurse should educate the patient on potential complications of the drug and the need to follow up. Pharmacists should verify dosing, and also given the extensive drug-drug interaction list for cyclosporine, thorough medication reconciliation is in order, with any red flags reported promptly to the rest of the healthcare team. Nursing can monitor both for treatment effectiveness as well as for adverse effects of the medication, alerting the treating physician to any concerns. Finally, patients on cyclosporine are at a slight risk of lymphoproliferative malignancies and infections; thus, a thorough history and physical exam are vital at each clinic visit.

CYclosporine therapy has a much higher opportunity for patient success with the communication and collaboration of an interprofessional healthcare team approach. [Level V]


Interested in Participating?

We are looking for contributors to author, edit, and peer review our vast library of review articles and multiple choice questions. In as little as 2-3 hours you can make a significant contribution to your specialty. In return for a small amount of your time, you will receive free access to all content and you will be published as an author or editor in eBooks, apps, online CME/CE activities, and an online Learning Management System for students, teachers, and program directors that allows access to review materials in over 500 specialties.

Improve Content - Become an Author or Editor

This is an academic project designed to provide inexpensive peer-reviewed Apps, eBooks, and very soon an online CME/CE system to help students identify weaknesses and improve knowledge. We would like you to consider being an author or editor. Please click here to learn more. Thank you for you for your interest, the StatPearls Publishing Editorial Team.

Cyclosporine - Questions

Take a quiz of the questions on this article.

Take Quiz
Which of the following drugs acts by inhibiting production of interleukin 2 from T cells?



Click Your Answer Below


Would you like to access teaching points and more information on this topic?

Improve Content - Become an Author or Editor and get free access to the entire database, free eBooks, as well as free CME/CE as it becomes available. If interested, please click on "Sign Up" to register.

Purchase- Want immediate access to questions, answers, and teaching points? They can be purchased above at Apps and eBooks.


Sign Up
Cyclosporine is a fungal polypeptide that acts by preventing production of:



Click Your Answer Below


Would you like to access teaching points and more information on this topic?

Improve Content - Become an Author or Editor and get free access to the entire database, free eBooks, as well as free CME/CE as it becomes available. If interested, please click on "Sign Up" to register.

Purchase- Want immediate access to questions, answers, and teaching points? They can be purchased above at Apps and eBooks.


Sign Up
What is the mechanism of action of cyclosporine?



Click Your Answer Below


Would you like to access teaching points and more information on this topic?

Improve Content - Become an Author or Editor and get free access to the entire database, free eBooks, as well as free CME/CE as it becomes available. If interested, please click on "Sign Up" to register.

Purchase- Want immediate access to questions, answers, and teaching points? They can be purchased above at Apps and eBooks.


Sign Up
Which drug is frequently associated with gout?



Click Your Answer Below


Would you like to access teaching points and more information on this topic?

Improve Content - Become an Author or Editor and get free access to the entire database, free eBooks, as well as free CME/CE as it becomes available. If interested, please click on "Sign Up" to register.

Purchase- Want immediate access to questions, answers, and teaching points? They can be purchased above at Apps and eBooks.


Sign Up
Cyclosporine has made a major impact on lung transplantation. What is the mechanism of action?



Click Your Answer Below


Would you like to access teaching points and more information on this topic?

Improve Content - Become an Author or Editor and get free access to the entire database, free eBooks, as well as free CME/CE as it becomes available. If interested, please click on "Sign Up" to register.

Purchase- Want immediate access to questions, answers, and teaching points? They can be purchased above at Apps and eBooks.


Sign Up
A patient develops tremors, hyperglycemia, hyperlipidemia, and cholelithiasis after being treated for Hodgkin lymphoma. What agent is most likely responsible?



Click Your Answer Below


Would you like to access teaching points and more information on this topic?

Improve Content - Become an Author or Editor and get free access to the entire database, free eBooks, as well as free CME/CE as it becomes available. If interested, please click on "Sign Up" to register.

Purchase- Want immediate access to questions, answers, and teaching points? They can be purchased above at Apps and eBooks.


Sign Up
Which of these agents inhibits interleukin 2 synthesis?



Click Your Answer Below


Would you like to access teaching points and more information on this topic?

Improve Content - Become an Author or Editor and get free access to the entire database, free eBooks, as well as free CME/CE as it becomes available. If interested, please click on "Sign Up" to register.

Purchase- Want immediate access to questions, answers, and teaching points? They can be purchased above at Apps and eBooks.


Sign Up
Following liver transplantation, a prescription is written for cyclosporine 600 mg oral solution to be given daily. What instruction should be given to the patient prior to discharge?



Click Your Answer Below


Would you like to access teaching points and more information on this topic?

Improve Content - Become an Author or Editor and get free access to the entire database, free eBooks, as well as free CME/CE as it becomes available. If interested, please click on "Sign Up" to register.

Purchase- Want immediate access to questions, answers, and teaching points? They can be purchased above at Apps and eBooks.


Sign Up
Cyclosporine, a fungal polypeptide, acts by preventing production of which interleukin?



Click Your Answer Below


Would you like to access teaching points and more information on this topic?

Improve Content - Become an Author or Editor and get free access to the entire database, free eBooks, as well as free CME/CE as it becomes available. If interested, please click on "Sign Up" to register.

Purchase- Want immediate access to questions, answers, and teaching points? They can be purchased above at Apps and eBooks.


Sign Up
Which of the following immunosuppressant drugs is commonly used after organ transplantation?



Click Your Answer Below


Would you like to access teaching points and more information on this topic?

Improve Content - Become an Author or Editor and get free access to the entire database, free eBooks, as well as free CME/CE as it becomes available. If interested, please click on "Sign Up" to register.

Purchase- Want immediate access to questions, answers, and teaching points? They can be purchased above at Apps and eBooks.


Sign Up
Select the medication that is most likely to affect renal function .



Click Your Answer Below


Would you like to access teaching points and more information on this topic?

Improve Content - Become an Author or Editor and get free access to the entire database, free eBooks, as well as free CME/CE as it becomes available. If interested, please click on "Sign Up" to register.

Purchase- Want immediate access to questions, answers, and teaching points? They can be purchased above at Apps and eBooks.


Sign Up
Hypertrichosis can be caused by which of the following medications?



Click Your Answer Below


Would you like to access teaching points and more information on this topic?

Improve Content - Become an Author or Editor and get free access to the entire database, free eBooks, as well as free CME/CE as it becomes available. If interested, please click on "Sign Up" to register.

Purchase- Want immediate access to questions, answers, and teaching points? They can be purchased above at Apps and eBooks.


Sign Up
Which is a common side effect of cyclosporine?



Click Your Answer Below


Would you like to access teaching points and more information on this topic?

Improve Content - Become an Author or Editor and get free access to the entire database, free eBooks, as well as free CME/CE as it becomes available. If interested, please click on "Sign Up" to register.

Purchase- Want immediate access to questions, answers, and teaching points? They can be purchased above at Apps and eBooks.


Sign Up
After a renal transplant, a patient who has been on cyclosporine for 5 months presents for his regular visit. Which of the following is not an adverse effect of cyclosporine?



Click Your Answer Below


Would you like to access teaching points and more information on this topic?

Improve Content - Become an Author or Editor and get free access to the entire database, free eBooks, as well as free CME/CE as it becomes available. If interested, please click on "Sign Up" to register.

Purchase- Want immediate access to questions, answers, and teaching points? They can be purchased above at Apps and eBooks.


Sign Up
What is the mechanism of action of cyclosporine?



Click Your Answer Below


Would you like to access teaching points and more information on this topic?

Improve Content - Become an Author or Editor and get free access to the entire database, free eBooks, as well as free CME/CE as it becomes available. If interested, please click on "Sign Up" to register.

Purchase- Want immediate access to questions, answers, and teaching points? They can be purchased above at Apps and eBooks.


Sign Up
After a lung transplant, a patient is given cyclosporine as part of their immunosuppression regimen. From the list below, select the mechanism of action for cyclosporine's immunosuppressive effect.



Click Your Answer Below


Would you like to access teaching points and more information on this topic?

Improve Content - Become an Author or Editor and get free access to the entire database, free eBooks, as well as free CME/CE as it becomes available. If interested, please click on "Sign Up" to register.

Purchase- Want immediate access to questions, answers, and teaching points? They can be purchased above at Apps and eBooks.


Sign Up
Post kidney transplant a patient is given cyclosporine to help prevent organ graft rejection. Which possible adverse responses are of greatest concern with this immunosuppressive drug?



Click Your Answer Below


Would you like to access teaching points and more information on this topic?

Improve Content - Become an Author or Editor and get free access to the entire database, free eBooks, as well as free CME/CE as it becomes available. If interested, please click on "Sign Up" to register.

Purchase- Want immediate access to questions, answers, and teaching points? They can be purchased above at Apps and eBooks.


Sign Up

Cyclosporine - References

References

Pradier A,Papaserafeim M,Li N,Rietveld A,Kaestel C,Gruaz L,Vonarburg C,Spirig R,Puga Yung GL,Seebach JD, Small-Molecule Immunosuppressive Drugs and Therapeutic Immunoglobulins Differentially Inhibit NK Cell Effector Functions {i}in vitro{/i}. Frontiers in immunology. 2019;     [PubMed]
2018 Aug;     [PubMed]
Ponticelli C,Glassock RJ, Prevention of complications from use of conventional immunosuppressants: a critical review. Journal of nephrology. 2019 Mar 29;     [PubMed]
Xin GLL,Khee YP,Ying TY,Chellian J,Gupta G,Kunnath AP,Nammi S,Collet T,Hansbro PM,Dua K,Chellappan DK, Current Status on Immunological Therapies for Type 1 Diabetes Mellitus. Current diabetes reports. 2019 Mar 23;     [PubMed]
Sun SL,Liu JJ,Zhong B,Wang JK,Jin X,Xu H,Yin FY,Liu TN,Chen QM,Zeng X, Topical calcineurin inhibitors in the treatment of oral lichen planus: a systematic review and meta-analysis. The British journal of dermatology. 2019 Mar 22;     [PubMed]
Liddicoat AM,Lavelle EC, Modulation of innate immunity by cyclosporine A. Biochemical pharmacology. 2019 Mar 15;     [PubMed]
Masi S,Uliana M,Gesi M,Taddei S,Virdis A, Drug-induced hypertension: Know the problem to know how to deal with it. Vascular pharmacology. 2019 Apr;     [PubMed]
Pal P,Giri PP,Sinha R, Cyclosporine in Resistant Systemic Arthritis - A Cheaper Alternative to Biologics. Indian journal of pediatrics. 2019 Apr 1;     [PubMed]
Shin HS,Grgic I,Chandraker A, Novel Targets of Immunosuppression in Transplantation. Clinics in laboratory medicine. 2019 Mar;     [PubMed]
Arslansoyu Camlar S,Soylu A,Kavukçu S, Cyclosporine in Pediatric Nephrology. Iranian journal of kidney diseases. 2018 Nov;     [PubMed]

Disclaimer

The intent of StatPearls is to provide practice questions and explanations to assist you in identifying and resolving knowledge deficits. These questions and explanations are not intended to be a source of the knowledge base of all of medicine, nor is it intended to be a board or certification review of Transplant Hepatology. The authors or editors do not warrant the information is complete or accurate. The reader is encouraged to verify each answer and explanation in several references. All drug indications and dosages should be verified before administration.

StatPearls offers the most comprehensive database of free multiple-choice questions with explanations and short review chapters ever developed. This system helps physicians, medical students, dentists, nurses, pharmacists, and allied health professionals identify education deficits and learn new concepts. StatPearls is not a board or certification review system for Transplant Hepatology, it is a learning system that you can use to help improve your knowledge base of medicine for life-long learning. StatPearls will help you identify your weaknesses so that when you are ready to study for a board or certification exam in Transplant Hepatology, you will already be prepared.

Our content is updated continuously through a multi-step peer review process that will help you be prepared and review for a thorough knowledge of Transplant Hepatology. When it is time for the Transplant Hepatology board and certification exam, you will already be ready. Besides online study quizzes, we also publish our peer-reviewed content in eBooks and mobile Apps. We also offer inexpensive CME/CE, so our content can be used to attain education credits while you study Transplant Hepatology.